GlassScriptPhysician profile
Juris Shibayama
NPI 1992758981
$40,309.98
in general payments reported to CMS, 2019-2025
10 companies · $4,947 in 2025
The $4,947 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $902 · 2022: $1,734 · 2023: $504 · 2024: $342 · 2025: $4,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,508 · Food and Beverage: $2,239 · Royalty Or License: $47.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,507.73 |
| Food and Beverage | $2,238.54 |
| Royalty Or License | $47.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $27,278.19 | 2019-2022 | |
| Globus Medical, INC. | $6,311.95 | 2019-2023 | Revere 6.35 |
| Arthrex, INC. | $2,925.24 | 2025 | |
| Music City Medical Technologies, LLC | $1,949.01 | 2024-2025 | |
| Zimvie INC. | $893.03 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $436.03 | 2022 | |
| Ebi, LLC | $372.98 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Si-Bone, INC. | $101.51 | 2020 | |
| Solventum Corporation | $23.48 | 2025 | Prevena |
| Augmedics INC. | $18.56 | 2024 | Xvision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juris Shibayama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.